Cart
sales@molnova.com
Jasmone
CAS No. 488-10-8
Jasmone( cis-?Jasmone )
Catalog No. M21336 CAS No. 488-10-8
Jasmone is a natural product isolated from the volatile portion of the oil from jasmine flowersas an insect semiochemical and in plant defense.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 83 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJasmone
-
NoteResearch use only, not for human use.
-
Brief DescriptionJasmone is a natural product isolated from the volatile portion of the oil from jasmine flowersas an insect semiochemical and in plant defense.
-
DescriptionJasmone is a natural product isolated from the volatile portion of the oil from jasmine flowersas an insect semiochemical and in plant defense.
-
In Vitro——
-
In Vivo——
-
Synonymscis-?Jasmone
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number488-10-8
-
Formula Weight164.24
-
Molecular FormulaC11H16O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (608.87 mM)
-
SMILESCC/C=C\CC1=C(C)CCC1=O
-
Chemical Name(E)-3-methyl-2-(pent-2-en-1-yl)cyclopent-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Birkett M. A Campbell C. A. M Chamberlain K等. New roles for cis-jasmone as an insect semiochemical and in plant defense[J]. Proceedings of the National Academy of Sciences of the United States of America 97(16):9329-9334.
molnova catalog
related products
-
Emicizumab
Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
-
Etilefrine pivalate ...
Etilefrine pivalate HCl is an orally active compound for the treatment of migraine headaches.
-
SKI II
SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.
